Missedย NVDA?
Donโt Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities โ for free.
Home โบ Stocks โบ SunOpta Inc. (STKL) Stock Forecast & Price Prediction United States | NASDAQ | Consumer Defensive | Beverages - Non-Alcoholic
$6.47
-0.03 (-0.46%)Did STKL Make This Month's Elite Buy List?
We don't follow just any analyst โ only the top 3% with a proven track record make our cut. See if SunOpta is one of their latest high-conviction picks.
Based on our analysis of 9 Wall Street analysts, STKL has a neutral consensus with a median price target of $8.00 (ranging from $6.50 to $8.00). The overall analyst rating is Strong Buy (8.0/10). Currently trading at $6.47, the median forecast implies a 23.6% upside. This outlook is supported by 3 Buy, 3 Hold, and 0 Sell ratings.
The most optimistic forecast comes from Brian Holland at DA Davidson, projecting a 23.6% upside. Conversely, the most conservative target is provided by Raimzhan Bayterek at Freedom Broker, suggesting a 0.5% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
These are the latest 20 analyst ratings and price targets for STKL.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Feb 9, 2026 | DA Davidson | Brian Holland | Buy | Maintains | $8.00 |
| Feb 6, 2026 | Freedom Broker | Raimzhan Bayterek | Hold | Downgrade | $6.50 |
| Dec 5, 2025 | Freedom Broker | Buy | Initiates | $N/A | |
| Dec 5, 2025 | Freedom Capital Markets | Raimzhan Bayterek | Buy | Initiates | $7.50 |
| Nov 6, 2025 | Mizuho | John Baumgartner | Outperform | Maintains | $8.00 |
| Jan 2, 2025 | Stephens & Co. | Jim Salera | Overweight | Reiterates | $10.00 |
| Nov 6, 2024 | Stephens & Co. | Jim Salera | Overweight | Maintains | $10.00 |
| Oct 10, 2024 | DA Davidson | Brian Holland | Buy | Maintains | $9.00 |
| Mar 5, 2024 | DA Davidson | Brian Holland | Buy | Maintains | $9.00 |
| Feb 29, 2024 | Canaccord Genuity | Bobby Burleson | Buy | Maintains | $9.00 |
| Feb 29, 2024 | BMO Capital | Andrew Strelzik | Outperform | Maintains | $10.00 |
| Dec 8, 2023 | DA Davidson | Brian Holland | Buy | Initiates | $8.00 |
| Nov 9, 2023 | BMO Capital | Andrew Strelzik | Outperform | Maintains | $9.00 |
| Oct 2, 2023 | Mizuho | John Baumgartner | Buy | Initiates | $9.00 |
| Aug 11, 2023 | Canaccord Genuity | Bobby Burleson | Buy | Maintains | $8.00 |
| Aug 10, 2023 | BMO Capital | Andrew Strelzik | Outperform | Maintains | $10.00 |
| Jun 23, 2023 | Stephens & Co. | Jim Salera | Overweight | Initiates | $10.00 |
| Mar 3, 2023 | BMO Capital | Andrew Strelzik | Outperform | Maintains | $12.00 |
| Aug 11, 2022 | BMO Capital | Andrew Strelzik | Outperform | Maintains | $13.00 |
| Sep 10, 2021 | Cowen & Co. | Outperform | Initiates | $N/A |
The following stocks are similar to SunOpta based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
SunOpta Inc. has a market capitalization of $767.41M with a P/E ratio of 49.8x. The company generates $817.72M in trailing twelve-month revenue with a 1.9% profit margin.
Revenue growth is +13.0% quarter-over-quarter, while maintaining an operating margin of +6.7% and return on equity of +9.0%.
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings โ tracked and updated every Monday and Thursday.
Produces plant-based and organic foods and beverages.
SunOpta generates revenue by sourcing, processing, and producing a variety of plant-based food products, primarily focusing on non-dairy milk alternatives and organic snacks. The company serves multiple sectors including retail and food service, catering to the increasing demand for healthy and sustainable food options.
Headquartered in Eden Prairie, Minnesota, SunOpta operates several manufacturing and sourcing facilities across North America. The company emphasizes organic and non-GMO products, aligning with consumer trends towards sustainability and ethical food choices.
Consumer Defensive
Beverages - Non-Alcoholic
1,248
Mr. Brian W. Kocher
United States
1990
SunOpta Inc. announced the early termination of the HSR Act waiting period for its acquisition by Refresco Holding B.V. at $6.50 per share in cash.
The early termination of the antitrust waiting period signals progress in SunOpta's acquisition by Refresco, potentially enhancing shareholder value and market confidence.
SunOpta Inc. announced that proxy advisory firms ISS and Glass Lewis recommend shareholders vote "FOR" its acquisition by Refresco at the upcoming special meeting.
The endorsement from ISS and Glass Lewis for SunOpta's acquisition by Refresco signals strong support for the deal, likely increasing shareholder confidence and potentially boosting stock value.
Kahn Swick & Foti is investigating SunOpta's proposed sale to Refresco, which offers $6.50 per share. They aim to assess the adequacy of this offer and the sales process.
The investigation into SunOpta's sale price may indicate potential undervaluation, affecting shareholder returns and influencing market perceptions of the deal's fairness.
SunOpta has filed a circular and proxy statement for a special meeting of voting shareholders and announced it has received an interim order.
SunOpta's filing indicates potential corporate changes or strategic decisions, which could impact shareholder value and influence stock performance.
In Q4, the Heartland Small Cap Value Strategy rose 2.98%, underperforming the Russell 2000ยฎ Value Index's 3.26%. Positive stock selection occurred, with biotech stocks performing well.
The Heartland Small Cap Value Strategy's slight underperformance relative to the Russell 2000ยฎ Value Index signals potential caution in small-cap investments, especially amid speculative biotech volatility.
Refresco will acquire SunOpta for $6.50 per share in cash, expanding its North American capabilities. The deal is expected to close in Q2 2026, pending customary conditions.
Refresco's acquisition of SunOpta enhances its market position and capabilities, potentially driving growth and profitability, which impacts stock valuations and investor sentiment.
Based on our analysis of 9 Wall Street analysts, SunOpta Inc. (STKL) has a median price target of $8.00. The highest price target is $8.00 and the lowest is $6.50.
According to current analyst ratings, STKL has 3 Buy ratings, 3 Hold ratings, and 0 Sell ratings. The stock is currently trading at $6.47. Always conduct your own research and consider your investment goals before making investment decisions.
Wall Street analysts predict STKL stock could reach $8.00 in the next 12 months. This represents a 23.6% increase from the current price of $6.47. Please note that this is a projection by Wall Street analysts and not a guarantee.
SunOpta generates revenue by sourcing, processing, and producing a variety of plant-based food products, primarily focusing on non-dairy milk alternatives and organic snacks. The company serves multiple sectors including retail and food service, catering to the increasing demand for healthy and sustainable food options.
The highest price target for STKL is $8.00 from Brian Holland at DA Davidson, which represents a 23.6% increase from the current price of $6.47.
The lowest price target for STKL is $6.50 from Raimzhan Bayterek at Freedom Broker, which represents a 0.5% increase from the current price of $6.47.
The overall analyst consensus for STKL is neutral. Out of 9 Wall Street analysts, 3 rate it as Buy, 3 as Hold, and 0 as Sell, with a median price target of $8.00.
Stock price projections, including those for SunOpta Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.